From September 20, 2023 to September 30, 2023, the company has repurchased 0 shares, representing 0% for CNY 0 million. With this, the company has completed the repurchase of 0 shares, representing 0% for CNY 0 million under the buyback announced on September 21, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
32.01 CNY | -2.47% | -8.88% | +4.89% |
04-22 | CSPC Innovation Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
04-19 | China's drugmakers can't sell mRNA shots but haven't quit yet | RE |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+4.89% | 6.39B | |
+16.86% | 8.48B | |
+5.05% | 7.6B | |
-5.23% | 3.75B | |
-6.58% | 3.71B | |
-3.55% | 1.36B | |
-28.64% | 1.11B | |
+18.12% | 1.02B | |
-8.60% | 924M | |
-17.08% | 785M |
- Stock Market
- Equities
- 300765 Stock
- News CSPC Innovation Pharmaceutical Co., Ltd.
- Tranche Update on CSPC Innovation Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on September 21, 2023.